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In this study, differentially expressed genes in peripheral blood from patients with Kashin-Beck disease and Keshan disease 
were compared to further investigate the etiology and pathogenesis of both diseases, which occur in a common endemic area of 
China. Twenty Kashin-Beck disease patients and 12 healthy controls, and 16 Keshan disease patients and 16 healthy controls, 
were grouped into four pairs. Patients and controls were selected from common endemic areas for the two diseases. Total RNA 
was isolated from peripheral blood mononuclear cells from all patients and controls, and gene expression profiles analyzed by 
oligonucleotide microarrays. Sixteen genes differentially expressed in both Kashin-Beck disease and Keshan disease (versus 
controls) were identified, and comprised nine genes showing synchronous and seven asynchronous expression. The Compara-
tive Toxicogenomics Database shows that expression and biological function of these genes can be affected by multiple envi-
ronmental factors, including mycotoxin and selenium content, potential environmental risk factors for the two diseases. Thus, 
these shared differentially expressed genes may contribute to the distinct organ lesions, caused by common environmental risk 
factors of Kashin-Beck disease and Keshan disease. 
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Kashin-Beck disease (KBD) and Keshan disease (KD) are 
major endemic diseases in China. The two diseases are dis-
tributed in a diagonal belt ranging from the northeast to the 
southwest of China, a region coincident with low environ-
mental selenium content. In China, there are >0.66 million 
KBD, 0.04 million KD patients, and with approximately 30 
million residents at risk [1,2]. KBD is an endemic osteoar-
thropathy, characterized by significant alterations in chon-
drocyte phenotype, necrosis and apoptosis, and abnormal 
terminal chondrocyte differentiation [3]. KD is an endemic 
myocardosis that mostly occurs in women and preschoolers, 
and is characterized by multifocal myocardial necrosis and 
fibrosis that can result in cardiogenic shock and congestive 
heart failure [4]. Because of articular cartilage and myocar-
dium deformities, the majority of KBD and KD patients 
partially or completely lose their working capacity, and 
even self-care abilities, which seriously impacts on their 
quality of life, and also increases the medical burden to   
society.  
The etiology and pathogenesis of KBD and KD are still  
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unclear. However, as both diseases typically occur in the 
same regions of China, and therefore share similar envi-
ronmental conditions, a common environmental etiological 
hypothesis has been proposed, with selenium deficiency and 
cereal contamination by mycotoxins likely factors [58]. 
Investigations have shown the selenium content is low in 
the internal and external environments of the endemic KBD 
and KD areas, resulting in residents with lower selenium 
content in blood, urine and hair than residents from 
non-endemic areas [9,10]. Mycotoxicosis has also been 
proposed as an etiological factor in both diseases, although 
the pathogenic fungus contributing to the two diseases is 
different; namely the T-2 toxin for KBD [11] and citreovi-
ridin for KD [8]. In addition to a shared endemic area, the 
living conditions of those affected by KBD and KD are 
similar, for example, patients tend to live either in remote 
rural areas or areas of backward transportation, have a low 
income and monotonous diet.  
Over the past decades, KBD and KD research has pre-
dominantly focused on pathogenic environmental factors, 
but recently gene expression microarray analyses have iden-
tified a set of abnormally expressed genes in KBD [12,13], 
but to date none has been identified for KD. Consequently, 
the interaction between genes and common environmental 
factors in KBD and KD development is now under debate. 
Comparing gene expression patterns should provide mecha-
nistic evidence for the differing organ lesions of KBD and 
KD that are caused by common environmental risk factors. 
To our knowledge, no research has yet been conducted 
comparing KBD and KD gene expression profiles.  
In this study, we used the Agilent Human 1A Oligo mi-
croarray to compare gene expression profiles of peripheral 
blood mononuclear cells (PBMCs) between KBD or KD 
patients and healthy controls, and identified the common 
genes differentially expressed in both diseases groups. Our 
aim was to investigate the underlying molecular mecha-
nisms and determine how common environmental factors 
affect KBD and KD pathology. Validity of identified oli-
gonucleotide array data was performed by parallel analyses 
of selected transcripts using quantitative real-time reverse 
transcription polymerase chain reaction (RT-PCR). 
1  Materials and methods 
All studies were approved by the Human Ethics Committee 
of Xi’an Jiaotong University. All patients and controls pro-
vided informed consent. 
1.1  Disease diagnosis and group categories 
All subjects were randomly chosen from Yongshou and 
Xunyi counties, both within Shaanxi Province, and there-
fore the same endemic area for both diseases. The preva-
lence rate of KBD and KD in the two counties above are 
17.4% and 13.9%. KBD and KD patients were diagnosed by 
using the National Diagnostic Criteria of Kashin-Beck Dis-
ease (WS/T 207-2010) or Keshan Disease (WS/T 210-2011) 
in China, respectively. Controls and KBD patients with a 
history of other bone and joint diseases were excluded from 
the study. Similarity controls and KD patients with a history 
of any other heart diseases were excluded from the study. 
Following study enrolment and exclusion criteria, 20 KBD 
patients and 12 normal subjects and 16 KD patients and 16 
normal subjects, chosen from endemic areas, were identi-
fied. The participants were divided into four pairs of KBD 
and control (KBD, n=5/pair; control, n=3/pair; Table 1), or 
KD and control (KD, n=4/pair; control, n=4/pair; Table 2). 
All subjects were of Chinese Han lineage, and were 
matched for age, gender and area.
Table 1   KBD-control pairs used for microarray analysis (set 1) and quantitative RT-PCR (set 2) analysesa) 
Sample pair 
KBD  Normal 
n Age (range) (years) Male Female  n Age (range) (years) Male Female 
Set 1          
1 5 47.20 (4155) 2 3  3 45.00 (3563) 1 2 
2 5 50.40 (4358) 2 3  3 48.67 (3968) 1 2 
3 5 50.20 (4067) 2 3  3 44.67 (3759) 1 2 
4 5 46.60 (3858) 3 2  3 51.00 (2754) 0 3 
Total 20 48.60 (3867) 9 11  12 44.84 (2768) 3 9 
Set 2          
1 3 57.67 (5560) 1 2  3 49.67 (4753) 1 2 
2 3 56.67 (5058) 1 2  3 50.00 (4555) 1 2 
Total 6 57.17 (5060) 2 4  6 49.83 (4555) 2 4 
a) Characteristics of the patients with KBD and control according to sets of sample pairs used for microarray and quantitative RT-PCR. 
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Table 2  KD-control pairs used for microarray analysis (set 1) and quantitative RT-PCR (set 2) analysesa) 
Sample pair 
KD  Normal 
n Age (range) (years) Male Female  n Age (range) (years) Male Female 
Set 1          
1 4 44.75 (3350) 4 0  4 52.00 (4256) 4 0 
2 4 41.25 (3046) 0 4  4 39.75 (3645) 0 4 
3 4 49.75 (4751) 0 4  4 48.25 (4749) 0 4 
4 4 57.12 (5562) 0 4  4 58.75 (5264) 0 4 
Total 12 48.60 (3867) 4 12  16 44.84 (3664) 4 12 
Set 2          
1 3 47.00 (4250) 3 0  3 44.00 (4052) 3 0 
2 3 47.33 (4252) 0 3  3 42.33 (2754) 0 3 
Total 6 47.16 (4252) 3 3  6 43.16 (2754) 3 3 
a) Characteristics of the patients with KD and control according to sets of sample pairs used for microarray and quantitative RT-PCR. 
1.2  Blood collection and PBMC isolation  
Peripheral blood (3 mL) from each subject was collected 
into heparinized vacutainer tubes (Becton Dickenson, San 
Jose, CA, USA) for gene expression analysis. Leukocyte 
cell numbers were determined using a Hemovet 950 (Drew 
Scientific, Oxford, CT, USA). PBMCs were separated from 
plasma by centrifuging blood at 1500×g for 20 min. Cell 
pellets were resuspended in Hanks’ balanced salt solution 
(Gibco BRL/Invitrogen, Carlsbad, CA, USA). Cell suspen-
sions were layered over 5 mL of Lympholyte-H (Cedarlane 
Labs, Hornby, Canada), in a 15 mL Falcon tube, and cen-
trifuged for 40 min at 1500×g. After rinsing twice with cold 
Hanks’ balanced salt solution, cells were stored in RNA 
later (Ambion Inc., Austin, TX, USA) until RNA isolation. 
1.3  RNA preparation 
Total RNA was isolated from PBMCs using Trizol reagent 
(Life Technologies Inc., Carlsbad, CA, USA) following the 
manufacturer’s recommended protocol. The quality and 
integrity of extracted total RNA were determined using a 
high resolution electrophoresis system (Agilent 2100 Bio-
analyzer, Agilent Technologies, Palo Alto, CA, USA). To 
avoid individual differences among subjects, 30 µL of total 
RNA was extracted from each individual subject and then 
mixed to form eight pairs of microarrays (Tables 1 and 2). 
1.4  Microarray hybridization  
Isolated total RNA from each KBD/control or KD/control 
pair was transcribed into complementary DNA (cDNA), and 
then reverse transcribed into cRNA and labeled with CyDye 
using Amino Allyl MessageAmp aRNA Kit (Ambion) ac-
cording to the manufacturer’s instructions. Before reverse 
transcription, RNase-free DNase I was used to remove re-
sidual genomic DNA from total RNA. For each pair, 0.5 µg 
of labeled cRNA was purified separately and then mixed 
together with hybridization buffer before applying to mi-
croarrays. The Agilent Human 1A Oligo microarray, con-
sisting of 21073 (60-mer) oligonucleotide probes spanning 
conserved exons across transcripts of targeted full-length 
genes, was used for microarray hybridization following the 
recommended protocol. Microarray slides were scanned 
using Gene-Pix 4000B (Axon Instruments Inc., Foster City, 
CA, USA), and GenePixPro 3.0 software (Axon Instruments 
Inc.) used to analyze the 16-bit TIFF images produced by 
the scanner. Ratio images for all spots were defined by ac-
cessing the gene list file describing the microarray location 
of each gene. After the average signal intensity was sub-
tracted from the median back intensity, gene expression 
data were imported into Excel spreadsheets (Microsoft 
Corp., Redmond, WA, USA) using Unigene and GenBank 
descriptors. Global normalization was conducted to calcu-
late relative expression levels between two samples using 
all detected genes. A detailed description of this normaliza-
tion process can be obtained at www.aglient.com.  
1.5  Gene expression analysis 
To identify differentially expressed genes, expression ratios 
were calculated for each gene, with 0.5 or 2.0 regarded as 
statistically significant. P-values were calculated using the 
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Erf(x) represents twice the integral of the Gaussian distribu-
tion, with a mean value of 0, variance of 0.5, and xdev the 
deviation of the log ratio from 0. This calculation provides 
the statistical significance of the log ratio for each feature 
(i.e., transcript level) between red and green channels. Only 
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P-values 0.05 were regarded as significant.  
1.6  Quantitative real-time PCR validation 
For quantitative real-time PCR of our microarray analysis, 
seven genes with expression ratio 0.5 or 2.0 were select-
ed. Total RNA was isolated from an additional 24 subjects, 
and prepared as for the oligonucleotide microarray analysis. 
RNA was then converted into complementary DNA (cDNA) 
using superscript II reverse transcriptase (Invitrogen, Karl- 
sruhe, Germany) and random primers. Quantitative RT-PCR 
was performed using the ABI7500 Real-Time PCR system 
(Applied Biosystems, Foster City, CA, USA) according to 
the manufacturer’s instructions. All primer and probe sets 
(HBA1, NM_000558; PF4, NM_002619; SAPS1, NM_ 
014931; B2M, NM_004048; HBB, NM_000518; APOA1, 
NM_000039; HBA2, NM_00517) were supplied by Taq-
Man Gene Expression Assays (Applied Biosystems). Glycer-
aldehyde-3-phosphate-dehydrogenase (GAPDH) was simul-
taneously assayed as an endogenous invariant control for data 
normalization. Paired t tests were performed to determine 
significance levels of expression differences for seven genes, 
between KBD or KD patients and normal controls. 
2  Results 
2.1  Comparative analysis of differentially expressed 
genes between KBD and KD 
We used the Agilent Human 1A Oligo microarray system  
to compare gene expression profiles in PBMCs from KBD 
or KD patients versus controls. We identified 136 differen-
tially expressed genes (53 up-regulated and 83 down-   
regulated), between KBD and normal controls, with an av-
erage ratio in 20381 genes. Moreover, comparing KD and 
normal controls, we identified 3310 differentially expressed 
genes (3154 up-regulated and 156 down-regulated), with an 
average ratio in 43376 genes. Comparing all identified dif-
ferentially expressed genes, we found 16 genes showing 
differential expression in both diseases, including nine with 
synchronous and seven with asynchronous expression (Ta-
bles 3 and 4). These 16 genes were subdivided into 11 cat-
egories, namely metabolism, cytochrome enzymes, tran-
scription related, G-protein related, receptor, cytokine factor, 
ion channel transport protein, signal transduction, hemato-
poietic related, interleukin and immune related.
Table 3  List of nine synchronous expression genes in KBD and KD patientsa) 
Gene name Symbol Public ID 
Fold change 
KBD KD 
Carbonic anhydrase I 









CREB regulated transcription coactivator 1 CRTC1 NM_015321 2.93±2.80 2.62±1.83 
Ladybird homeobox 1 LBX1 NM_006562 2.42±2.07 2.05±1.06 
G protein-coupled receptor 153 GPR153 NM_207370 2.29±2.12 2.23±1.33 
Hemoglobin, delta HBD NM_000519 2.41±0.98 2.04±0.83 
Synuclein, alpha SNCA NM_000345 2.95±1.52 2.37±0.22 
Pleiotrophin PTN NM_002825 2.11±1.10 2.75±0.48 
Solute carrier family 9, subfamily A SLC9A9 NM_173653 0.37±0.06 0.49±0.29 
a) Common differential expression genes between the KBD vs. controls and the KD vs. controls were assessed using the selection criteria described in 
Materials and methods. According to the fold change value, only those genes showing significant differences (P-value<0.05) in expression and screening the 
common differential expression genes in KBD and KD are listed. Fold change, the mean and standard error of the mean (SEM) of the fold change in expres-
sion of each gene. 
Table 4  List of seven asynchronous expression genes in KBD and KD patientsa) 
Gene name Symbol Public ID 
Fold change 
KBD KD 
ATP/GTP binding protein-like 4 
Ankyrin repeat domain 20 family, member A2 
Calcium channel, voltage-dependent, gamma subunit 6 
Hemoglobin, alpha2 
Hemoglobin, alpha1 
Interleukin 1 family, member 10 





























a) Common differential expression genes between the KBD vs. controls and the KD vs. controls were assessed using the selection criteria described in 
Materials and methods. According to the fold change value, only those genes showing significant differences (P-value<0.05) in expression and screening the 
common differential expression genes in KBD and KD are listed. Fold change, the mean and standard error of the mean (SEM) of the fold-change in expres-
sion of each gene. 
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2.2  Quantitative RT-PCR analysis  
To validate the microarray data, seven differentially ex-
pressed genes were selected for quantitative RT-PCR analy-
sis using PBMC samples from an additional 12 KBD and 12 
KD subjects. Expression levels of HBA1, PF4, SAPS1, 
B2M, HBB, APOA1 and HBA2 mRNA in KBD and KD 
PBMCs, were significantly different from normal control 
PBMCs (Figure 1). Thus, our quantitative RT-PCR analysis 
confirms the oligonucleotide array results. 
3  Discussion 
KBD and KD are distributed within the same geographical 
area, although the clinical manifestation and target patho-
logical organs are not identical (articular cartilage and epi-
physeal plates mainly injured in KBD, and myocardial 
damage present in KD). In this study, we used oligonucleo-
tide microarrays to compare PBMC gene expression pro-
files between KBD or KD patients and normal controls. We 
identified differentially expressed genes in both KBD and 
KD (versus healthy controls), which may help identify the  
underlying mechanisms of the distinct organ lesions, caused 
by common environmental risk factors of KBD and KD. 
3.1  Functions of genes with synchronous expression in 
KBD and KD 
The nine genes showing synchronous expression in KBD 
and KD include CA1, COX6A2, HBD, LBX1 and PTN. 
These genes belong to various functional categories, in-
cluding metabolism, transcription related, ion channel 
transport protein, hematopoietic related and immune related. 
Carbonic anhydrases (CA1) belong to a large family of 
metalloenzymes that catalyze reversible hydration of carbon 
dioxide (CO2). They participate in a variety of biological 
processes, including respiration calcification, acid-base  
 
 
Figure 1  The expression ratio comparison of the selected gene between 
the microarray and quantitative RT-PCR. Histogram shows the expression 
ratio of the seven selected genes, as measured by microarray and quantita-
tive RT-PCR. * indicates P<0.05, calculated by Student’s paired t-test. 
balance, and bone resorption. Overexpressed CA1 in syno-
vial tissue of ankylosing spondylitis contributes to abnormal  
bone calcification and bone resorption [14]. Myocardium 
respiratory disturbances, such as anoxia, cell ischemia and 
abnormal lipid-conformation of the erythrocyte membrane, 
are pathological of KD [15]. The main physiological func-
tion of CA is transportation of CO2 from tissues to plasma 
[16]; therefore CA1 overexpression in KD patients may be 
requirement for increased CO2 transportation via carbonic 
anhydrase, because of increased CO2 concentration as a re-
sult of anoxia and cardiomyocyte ischemia. Thus, CA1 may 
play an important role in progress of both KBD and KD, but 
there is little research on the relationship between CA1 and 
environment interactions. 
COX6A2 encodes cytochrome c oxidase, the terminal 
enzyme in the mitochondrial respiratory chain which cata-
lyzes electron transfer from reduced cytochrome c to oxy-
gen, and reduction of oxygen to water molecules to main-
tain reactive oxygen within mitochondria at a normal physi-
ological level [17]. In KBD patients, reactive oxygen con-
tent is increased in articular chondrocytes, and cytochrome c 
is released from mitochondria to cytoplasm which stimu-
lates apoptosis [18]. Moreover, in the cardiomyocyte of KD 
patients, cytochrome c oxidase activity is reduced [15], and 
animal experiments have shown cytochrome c oxidase ac-
tivity through increased citreoviridin dosage [19]. Further-
more, low selenium has an inhibitory action on cytochrome 
c oxidase activity in mouse cardiomyocytes [20]. Therefore, 
COX6A2 overexpression, interacting with the same envi-
ronment factors, may play a key role in pathogenesis of the 
two diseases. 
Pleiotrophin (PTN) is a cell growth factor that promotes 
angiogenesis, cell proliferation and differentiation. PTN 
contributes to chondrogenesis and prevents cartilage degen-
eration [21,22]. PTN expression is elevated during the early 
stages of osteoarthritis in patients [23], and PTN may be 
involved in synovial angiogenesis, as it is the angiogenic 
factor generated in the inflammatory reaction of rheumatoid 
arthritis [24]. Moreover, PTN overexpression occurs in di-
lated cardiomyopathy, supporting neovascularization due to 
heart damage, and can also reduce the cardiomyocyte reac-
tion to hypoxia and promote neonatal cardiomyocytes 
apoptosis by suppressing activity of AKT/PKB [25]. There- 
fore, PTN may play an important role in KBD and KD de-
velopment. 
3.2  Function of genes with asynchronous expression in 
KBD and KD 
The seven genes showing asynchronous expression in KBD 
and KD include HBA1, HBA2, IL1F10 and CACNG6. 
These genes belong to various functional categories, in-
cluding metabolism, signal transduction, ion channel trans- 
port protein, hematopoietic related, interleukin and immune 
related. 
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Hemoglobin alpha chains 1 and 2 (HBA1 and HBA2) are 
up-regulated in KBD, and down-regulated in KD patients. 
The HbA molecule comprises two alpha and two beta 
chains, which during normal adult life comprises approxi-
mately 97% of total hemoglobin. Abnormal erythrocyte 
membrane structures is present in both KBD and KD [26]. 
Hemoglobin form can affect erythrocyte membrane struc-
ture [27], and low selenium levels can disorder the ultra-
structure and function of erythrocyte membrane [28]. It has 
been well reported that hemoglobin content in patients with 
heart failure, as found in KD, is significantly lower than 
normal controls [29–31]. In addition, the selenium content 
of erythrocyte and erythrocyte membranes in KBD patients 
is lower than normal controls [32]. Therefore, it is feasible 
that co-influences from environmental factors (low seleni-
um and mycotoxins) and different alterations in gene ex-
pression (HBA1 and HBA2) may contribute to abnormal 
erythrocyte membrane structures in KBD and KD patients. 
The reason for differential expression of HBA1 and HBA2 
(up-regulated in KBD, and down-regulated in KD) may 
involve the differing disease pathogenesis and target organs.  
Interleukin-1 (IL-1) is a pleiotropic cytokine and deter-
mining factor in the mechanism of inflammatory pathogen-
esis. In osteoarthritis patients, IL1 is involved in cartilage 
degradation and the inflammatory reaction between syno-
vium and cartilage [33]. IL-1 content in the synovium and 
serum of KBD and osteoarthritis patients is significantly 
elevated [34,35], and KBD is associated with suppressed 
immunity in PBMCs [36]. An IL-1 polymorphism has been 
found associated with KBD and rheumatoid arthritis [37,38]. 
IL1F10 expression is found in heart, placenta and spleen 
[39], and increased IL-1 expression occurs in coronary heart 
disease, myocardial infarction and cardiac failure patients 
[40], consistent with IL1F10 overexpression in KD patients. 
IL1 is also an important moderator of hypertrophy, fibrosis 
and myocardium insufficiency. However, the relationship 
between IL1F10 down-regulation and increasing IL1 is un-
clear, but our microarray results suggest IL1 cytokines, en-
coded by IL1F10, play an important role in KBD and KD 
pathogenesis. 
CACNG6 encodes a gamma subunit of the calcium 
channel, a channel specifically for calcium ion transport 
across cell membranes. Calcium channels are crucial for 
osteoblast differentiation to osteocytes and osteoclasts, and 
both calcium ions and calcium channels play critical roles in 
apoptosis [41]. A number of hormones and cytokines that 
act directly on osteoblasts are regulated by calcium ions (via 
calcium channels) [42]. It has been reported that decreased 
calcium channel density is present in myocardial hypertro-
phy and cardiac failure [43]. We detected up-regulated and 
down-regulated CACNG6 expression in KBD and KD pa-
tients, respectively, suggesting that CACNG6 is involved in 
pathogenesis of both endemic diseases.  
Using the Comparative Toxicogenomics Database, we 
found that among the 16 genes differentially expressed in 
KBD and KD, expression and function of some genes are 
affected by selenium and mycotoxins, the environmental 
risk factors for KBD and KD. For example, HBA2 and 
CRTC1 expression is altered by selenium content in vivo, 
and mycotoxins can affect SLC9A9, COX6A2, GPR153 
and PTN gene expression. A detailed description of the 
genes listed can be obtained (www.ctdbase.org). Based on 
our results, and those of previous studies, we suggest that 
exposure to common environmental risk factors (mycotox-
ins and low selenium) leads to dysfunction of key genes, 
and contributes to specific organ lesions in KBD and KD. 
In summary, we compared PBMC gene expression pro-
files between KBD or KD patients and normal controls to 
investigate the same hypothesis and epidemiological char-
acteristics of both two diseases at the molecular level. In 
KBD and KD, identical environmental susceptibility genes 
varying in expression levels may combine on a common 
environmental background to play an important role in dis-
ease pathogenesis through an environment-gene related in-
teraction.  
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